Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) Revenue (2016 - 2025)

Historic Revenue for AC Immune (ACIU) over the last 12 years, with Q3 2025 value amounting to $1.2 million.

  • AC Immune's Revenue fell 9600.94% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 8316.02%. This contributed to the annual value of $31.2 million for FY2024, which is 8682.65% up from last year.
  • AC Immune's Revenue amounted to $1.2 million in Q3 2025, which was down 9600.94% from $1.6 million recorded in Q2 2025.
  • Over the past 5 years, AC Immune's Revenue peaked at $29.4 million during Q3 2024, and registered a low of -$163504.1 during Q1 2022.
  • In the last 5 years, AC Immune's Revenue had a median value of $221522.7 in 2021 and averaged $2.2 million.
  • Its Revenue has fluctuated over the past 5 years, first plummeted by 749129.15% in 2022, then surged by 9982869.04% in 2024.
  • Quarter analysis of 5 years shows AC Immune's Revenue stood at $624673.2 in 2021, then tumbled by 100.17% to -$1038.0 in 2022, then surged by 35614.18% to $368644.9 in 2023, then soared by 252.08% to $1.3 million in 2024, then dropped by 9.56% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $1.6 million for Q2 2025, and $1.1 million during Q1 2025.